National Health Investors Inc

Name: National Health Investors Inc standardized financial statements, quarterly
Creator: Listed

NHINYSECIK 877860Real estateFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$44.8m, Q2 FY2026

Net income$55.7m, Q2 FY2026

National Health Investors Inc, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	12.4	12.9	13.3	13.4	13.8	14.0	13.9	14.2	21.2	30.7	37.1	44.8
Operating income	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Interest expense	$m	15.1	14.9	14.9	14.9	14.9	15.2	14.3	15.0	13.8	14.3	15.0	15.8
Income tax	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	0.0	not reported	not reported	not reported	0.7
Net income	$m	29.3	32.0	30.9	35.3	28.5	43.2	34.2	37.0	32.9	38.2	40.1	55.7
Diluted EPS	$ per share	0.68	not reported	0.71	0.81	0.65	not reported	0.74	0.79	0.69	not reported	0.82	1.15
Basic EPS	$ per share	0.68	not reported	0.71	0.81	0.66	not reported	0.75	0.79	0.69	not reported	0.83	1.15

Balance sheet

Cash and equivalents$30.4m, Q2 FY2026

Shareholders' equity$1.57bn, Q2 FY2026

National Health Investors Inc, balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	16.6	22.3	11.4	14.8	15.6	24.3	135	18.6	81.6	19.6	24.9	30.4
Total assets	$m	2,499	2,488	2,478	2,477	2,460	2,614	2,783	2,696	2,690	2,797	2,890	2,964
Total liabilities	$m	1,218	1,214	1,211	1,213	1,213	1,229	1,338	1,199	1,192	1,257	1,357	1,375
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	1,260	1,254	1,248	1,244	1,229	1,366	1,426	1,480	1,481	1,522	1,515	1,571

Cash flow

Operating cash flow$65.0m, Q2 FY2026

Capital expenditure$109.4m, Q1 FY2026

Share repurchases$0, Q4 FY2023

National Health Investors Inc, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	49.7	53.2	40.8	60.7	48.6	57.6	46.5	59.8	62.5	67.7	53.4	65.0
Capital expenditure	$m	not reported	not reported	not reported	not reported	not reported	111	85.2	not reported	not reported	143	109	not reported
Dividends paid	$m	39.1	39.1	39.1	39.1	39.1	39.3	41.1	42.0	42.7	43.8	44.4	44.6
Share repurchases	$m	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)48.50m, Q2 FY2026

National Health Investors Inc, shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	44.4	43.4	43.4	43.4	43.4	43.6	44.0	45.9	46.8	47.6	48.5	48.5

Shares outstanding: 49.11m at Aug 3, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. Listed shows no prices and gives no investment advice.